Related Experiment Video
Updated: Apr 3, 2026

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting
Published on: December 9, 2022
[WNK-SPAK-SLC12A signal cascade is a new therapeutic target for hypertension]
Abstract:
WNK-oxidative stress-responsive 1 (OSR1) /STE20/SPS1-related proline-alanine-rich protein kinase(SPAK)-SLC12A transporters cascade regulates blood pressure through NaCl reabsorption in kidney and vasoconstriction. Furthermore, we recently reported that this cascade is positively regulated by insulin, which may contribute to hypertension in patients with hyperinsulinemia. Therefore, drugs that inhibit this signal cascade could become new antihypertensive drugs that have dual effects as a diuretic and vasodilator and be particularly beneficial for patients with hyperinsulinemia such as metabolic syndrome and obesity. In this review, we provide an overview about the current understanding about WNK-SPAK-SLC12A signal cascade and show some prospects for drug discovery that blocks this signal cascade.
Insights
The WNK-OSR1/SPAK-SLC12A cascade controls blood pressure. Inhibiting this pathway offers a potential dual-action antihypertensive therapy, especially for hyperinsulinemia patients.
Area of Science:
- Biochemistry
- Physiology
- Pharmacology
Background:
- The WNK-OSR1/SPAK-SLC12A cascade regulates blood pressure via kidney NaCl reabsorption and vasoconstriction.
- Insulin positively regulates this cascade, potentially linking hyperinsulinemia to hypertension.
Purpose of the Study:
- To review the current understanding of the WNK-SPAK-SLC12A signaling cascade.
- To explore prospects for developing drugs that inhibit this cascade for antihypertensive therapy.
Main Methods:
- Literature review of the WNK-SPAK-SLC12A signaling pathway.
- Analysis of the role of insulin in regulating the cascade.
- Discussion of potential drug targets and therapeutic strategies.
Main Results:
- The WNK-OSR1/SPAK-SLC12A cascade is a key regulator of NaCl transport and blood pressure.
- Insulin's positive regulation of the cascade suggests a role in insulin-related hypertension.
- Inhibitors of this cascade may offer dual diuretic and vasodilator effects.
Conclusions:
- The WNK-OSR1/SPAK-SLC12A cascade represents a promising target for novel antihypertensive drug discovery.
- Such drugs could be particularly effective in patients with metabolic syndrome and obesity due to hyperinsulinemia.
More Related Videos
08:08Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta
Published on: June 10, 2015
09:29Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
Published on: March 5, 2019
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Antihypertensive Drugs: Vasodilators
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers